Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy

Tomasz M. Beer, Bryan Goldman, Craig R. Nichols, Daniel P. Petrylak, Manoj Agarwal, Christopher W. Ryan, E. David Crawford

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences